Using Biology to Make Vaccine Adjuvants More Available
Biosciences Area Senior Faculty Researcher Jay Keasling and his research team have spent the past few decades engineering yeast to be tiny factories that more efficiently produce molecules that are typically found in small supply in nature. Now, they have modified yeast to make the adjuvant QS-21, an important additive to vaccines that stimulates the … Read more »
More »